Subscribe To Receive Email Updates
Categories
Topics
Archives
Tag Archives: Drug Reactions
Tracking Drugs for Consumer Safety
The Institute of Medicine (IOM) is taking the U.S. Food and Drug Administration (FDA) to task. In a new report, the IOM says the FDA should conduct more regular reviews of drugs to better catch and track safety issues. In …
Dangerous Top Ten Drugs
The Top Ten of anything usually designates the ‘best’ but not in this case. An online report from Adverse Events Inc., an independent company that analyzes the FDA’s database of Adverse Event Reporting System (AERS), has just issued its Top …
Lawmakers Looking Out for Consumers — Has Hell Frozen Over?
I was thrilled to hear that some of our elected members of Congress are finally working on proactive legislation that might benefit all of us. This is especially encouraging after watching with much discouragement the high level of discord and …
Bayer Bean Counters, Balloons and Dangerous Drugs
Has it simply become all about bean counters and number crunching for some drug companies?
If you can generate over $1.5 billion in sales for (5) years, for a drug you know is defective, can you afford to pay the claims that result from people being hurt or killed?
The Basic Problem With Pradaxa (Dabigatran Etexilate)
In 2010, the U.S. Food & Drug Administration approved Pradaxa (Dabigatran Etexilate). Pradaxa acts as a blood “thinner” and is promoted to reduce the risk of stroke and blood clots in people with atrial fibrillation. Atrial fibrillation, affecting over two …
Rushed Pharma Leads to Bad Karma — The Tale of Pradaxa
Pradaxa (dabigatran etexilate mesylate), a new oral anticoagulant, achieved Food & Drug Administration (“FDA”) approval on October 19, 2010. One notable advantage of using Pradaxa to replace Warfarin to prevent clot formation is the elimination of INR testing in patients taking Pradaxa. INR is the acronym for International Normalized Ratio, which is used to monitor the effectiveness of anticoagulant such as warfarin.
